Cited by 263Gastrointestinal motility and disordersGut microbiota and healthMicroscopic Colitis

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome

Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., Sokol, H., Coffin, B., Sabaté, J. M.·2012·Neurogastroenterology & Motility

DOI 10.1111/j.1365-2982.2012.01893.x

Open this paper in CoChat — free account

Abstract

Background Irritable bowel syndrome (IBS) is a multifactorial disease for which a dysbiosis of the gut microbiota has been described. Bile acids (BA) could play a role as they are endogenous laxatives and are metabolized by gut microbiota. We compared fecal BA profiles and microbiota in healthy subjects (HS) and patients with diarrhea‐predominant IBS (IBS‐D), and we searched for an association with symptoms. Methods Clinical features and stool samples were collected in IBS‐D patients and HS. Fecal BA profiles were generated using HPLC coupled to tandem mass spectrometry. The fecal microbiota composition was assessed by q‐PCR targeting dominant bacterial groups and species implicated in BA transformation. Key Results Fourteen IBS‐D patients and 18 HS were included. The two groups were comparable in terms of age and sex. The percentage of fecal primary BA was significantly higher in IBS‐D patients than in HS, and it was significantly correlated with stool consistency and frequency. Fecal counts of all bacteria, lactobacillus, coccoides, leptum and Faecalibacterium prausnitzii were similar. There was a significant increase of Escherichia coli and a significant decrease of leptum and bifidobacterium in IBS‐D patients. Conclusions & Inferences We report an increase of primary BA in the feces of IBS‐D patients compared to HS, correlated with stool consistency and frequency. A dysbiosis of different bacterial groups was detected, some of them involved in BA transformation. As the gut microbiota is the exclusive pathway to transform primary into secondary BA, this suggests a functional consequence of dysbiosis, leading to lower BA transformation.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2982.2012.01893.x

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Functional Bowel Disorders
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Self-citation
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,423
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Self-citation
The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699
Colonic Secretion of Water and Electrolytes Induced by Bile Acids: Perfusion Studies in Man
Mekhjian, H. S., Phillips, S. F., & Hofmann, A. F. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106644 · Cited by 584
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR
Furet, J., Firmesse, O., Gourmelon, M., Bridonneau, C., Tap, J., Mondot, S., Dore, J. M., & Corthier, G. (2009) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2009.00671.x · Cited by 431
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers
Krogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L. G., Mäkivuokko, H., Kajander, K., & Palva, A. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-95 · Cited by 307

Show all 42 references

Sorted by citations

Faecalibacterium prausnitzii and human intestinal health
Miquel, S., Martín, R., Rossi, O., Bermúdez‐Humarán, L. G., Chatel, J., Sokol, H., Thomas, M., Wells, J. M., & Langella, P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.003 · Cited by 1,282
Self-citation
The Human Gut Microbiome – A Potential Controller of Wellness and Disease
Kho, Z. Y., & Lal, S. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01835 · Cited by 1,180
Faecalibacterium prausnitzii : from microbiology to diagnostics and prognostics
López‐Siles, M., Duncan, S. H., Garcia-Gil, L. J., & Martínez-Medina, M. (2017) · The ISME Journal · doi:10.1038/ismej.2016.176 · Cited by 892
Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
Sinha, S. R., Haileselassie, Y., Nguyen, L. P., Tropini, C., Wang, M., Becker, L. S., Sim, D., Jarr, K. J., Bishop, E. S., Singh, G., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.021 · Cited by 880
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Kakiyama, G., Pandak, W. M., Gillevet, P. M., Hylemon, P. B., Heuman, D. M., Daita, K., Takei, H., Muto, A., Nittono, H., Ridlon, J. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.003 · Cited by 797
Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review
Pittayanon, R., Lau, J. T., Yuan, Y., Leontiadis, G. I., Tse, F., Surette, M., & Moayyedi, P. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.049 · Cited by 719
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome
Tap, J., Derrien, M., Törnblom, H., Brazeilles, R., Cools-Portier, S., Doré, J., Störsrud, S., Le Nevé, B., Öhman, L., & Simrén, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.049 · Cited by 642
Pathophysiology of irritable bowel syndrome
Holtmann, G. J., Ford, A. C., & Talley, N. J. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30023-1 · Cited by 590
Faecalibacterium : a bacterial genus with promising human health applications
Martín, R., Ríos-Covián, D., Huillet, E., Auger, S., Khazaal, S., Bermúdez‐Humarán, L. G., Sokol, H., Chatel, J., & Langella, P. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad039 · Cited by 630
Self-citation
Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice
Natividad, J. M., Lamas, B., Pham, H., Michel, M., Rainteau, D. P., Bridonneau, C., Costa, G. D., Vlieg, J. V. H., Sovran, B., Chamignon, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05249-7 · Cited by 559
Self-citation
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533
Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity
Nicolucci, A. C., Hume, M. P., Martínez, I., Mayengbam, S., Walter, J., & Reimer, R. A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.055 · Cited by 529
Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea‐predominant irritable bowel syndrome
Blake, M. R., Raker, J. M., & Whelan, K. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13746 · Cited by 495
Interactions between gut bacteria and bile in health and disease
Long, S. L., Gahan, C. G. M., & Joyce, S. A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.06.002 · Cited by 495
Bile acids as modulators of gut microbiota composition and function
Larabi, A. B., Masson, H. L. P., & Bäumler, A. J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2172671 · Cited by 443
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome
Camilleri, M., Lasch, K. L., & Zhou, W. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00155.2012 · Cited by 412
Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
Moloney, R. D., Johnson, A. C., O’Mahony, S. M., Dinan, T. G., Meerveld, B. G., & Cryan, J. F. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12490 · Cited by 412
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome
Pozuelo, M., Panda, S., Santiago, A., Mendez, S., Accarino, A. M., Santos, J., Guarner, F., Azpiroz, F., & Manichanh, C. (2015) · Scientific Reports · doi:10.1038/srep12693 · Cited by 338
Linking the gut microbiota to human health
Robles, V., & Guarner, F. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512005235 · Cited by 313
Peripheral mechanisms in irritable bowel syndrome
Camilleri, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1207068 · Cited by 300
Irritable bowel syndrome: a gut microbiota-related disorder?
Bhattarai, Y., Muniz Pedrogo, D. A., & Kashyap, P. C. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00338.2016 · Cited by 294
Peripheral Mechanisms in Irritable Bowel Syndrome
Kassam, Z., Collins, S. M., & Moayyedi, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1214185 · Cited by 285
Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis
Liu, H.-N., Wu, H., Chen, Y.-Z., Chen, Y.-J., Shen, X.-Z., & Liu, T.-T. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.142 · Cited by 254
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology
Saulnier, D. M., Ringel, Y., Heyman, M. B., Foster, J. A., Bercik, P., Shulman, R. J., Versalovic, J., Verdu, E. F., Dinan, T. G., Hecht, G., et al. (2013) · Gut Microbes · doi:10.4161/gmic.22973 · Cited by 248
Irritable bowel syndrome, the microbiota and the gut-brain axis
Raskov, H., Burcharth, J., Pommergaard, H.-C., & Rosenberg, J. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1218585 · Cited by 243
Mechanisms and efficacy of dietary FODMAP restriction in IBS
Staudacher, H. M., Irving, P. M., Lomer, M. C. E., & Whelan, K. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.259 · Cited by 252
Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health
Joyce, S. A., & Gahan, C. G. M. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033159 · Cited by 241
Bile Acid Diarrhea: Prevalence, Pathogenesis, and Therapy
Camilleri, M. (2015) · Gut and Liver · doi:10.5009/gnl14397 · Cited by 243
Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies
Wang, L., Alammar, N., Singh, R., Nanavati, J., Song, Y., Chaudhary, R., & Mullin, G. E. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.05.015 · Cited by 251
Intestinal Bacteria Interplay With Bile and Cholesterol Metabolism: Implications on Host Physiology
Molinero, N., Ruíz, L., Sánchez, B., Margollés, A., & Delgado, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00185 · Cited by 233
Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
Presti, A. L., Zorzi, F., CHIERICO, F. D., Altomare, A., Cocca, S., Avola, A., Biasio, F. D., Russo, A., Cella, E., Reddel, S., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01655 · Cited by 228
A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies
Rodiño‐Janeiro, B. K., Vicario, M., Alonso, C., Pascua-García, R., & Santos, J. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0673-5 · Cited by 223
Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS
Bajor, A., Törnblom, H., Rudling, M., Ung, K., & Simrén, M. (2014) · Gut · doi:10.1136/gutjnl-2013-305965 · Cited by 215
A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome
Zhao, L., Yang, W., Chen, Y., Huang, F., Lu, L., Lin, C., Huang, T., Ning, Z., Zhai, L., Zhong, L. L. D., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130976 · Cited by 202
Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome
Shin, A., Camilleri, M., Vijayvargiya, P., Busciglio, I., Burton, D., Ryks, M., Rhoten, D., Lueke, A., Saenger, A., Girtman, A., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.020 · Cited by 192
Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies
Shanahan, F., & Quigley, E. M. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.050 · Cited by 172
Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice
Ke, X., Walker, A., Haange, S., Lagkouvardos, I., Liu, Y., Schmitt‐Kopplin, P., von Bergen�, M., Jehmlich, N., He, X., Clavel, T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.012 · Cited by 168
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
Xiao, L., Liu, Q., Luo, M., & Xiong, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.729346 · Cited by 168
Fecal Microbial and Metabolic Profiles in Dogs With Acute Diarrhea Receiving Either Fecal Microbiota Transplantation or Oral Metronidazole
Chaitman, J., Ziese, A.-L., Pilla, R., Minamoto, Y., Blake, A. B., Guard, B. C., Isaiah, A., Lidbury, J. A., Steiner, J. M., Unterer, S., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00192 · Cited by 164
Irritable bowel syndrome: the role of food in pathogenesis and management.
Hayes, P. A., Fraher, M., & Quigley, E. M. M. (2014) · Europe PMC (PubMed Central) · Cited by 159
Exploring the human microbiome from multiple perspectives: factors altering its composition and function
Rojo, D., Méndez–García, C., Raczkowska, B. A., Bargiela, R., Moyá, A., Ferrer, M., & Barbas, C. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw046 · Cited by 166
The human microbiome and bile acid metabolism: Dysbiosis, dysmetabolism, disease and intervention
Jones, M. L., Martoni, C. J., Ganopolsky, J. G., Labbé, A., & Prakash, S. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.880420 · Cited by 150
Bacterial Bile Metabolising Gene Abundance in Crohn's, Ulcerative Colitis and Type 2 Diabetes Metagenomes
Labbé, A., Ganopolsky, J. G., Martoni, C., Prakash, S., & Jones, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115175 · Cited by 149
Gut microbiome alterations in patients with stage 4 hepatitis C
Mahmoud, A., Adel, A., EL-Gendy, A. O., Essam, T. M., & Aziz, R. K. (2016) · Gut Pathogens · doi:10.1186/s13099-016-0124-2 · Cited by 151
Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer
Lopez-Siles, M., Martinez-Medina, M., Surís-Valls, R., Aldeguer, X., Sabat-Mir, M., Duncan, S. H., Flint, H. J., & Garcia-Gil, L. J. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000590 · Cited by 144
Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
Bennet, S., Öhman, L., & Simrén, M. (2015) · Gut and Liver · doi:10.5009/gnl14344 · Cited by 144
Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids
Yang, T., Shu, T., Liu, G., Mei, H., Zhu, X., Huang, X., Zhang, L., & Jiang, Z. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.05.015 · Cited by 143
The gut microbiota as a therapeutic target in IBD and metabolic disease: a role for the bile acid receptors FXR and TGR5
Baars, A., Oosting, A., Knol, J., Garssen, J., & Van Bergenhenegouwen, J. (2015) · Microorganisms · doi:10.3390/microorganisms3040641 · Cited by 135
Clinical Consequences of Diet-Induced Dysbiosis
Chan, Y. K., Estaki, M., & Gibson, D. L. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000354902 · Cited by 140
Interplay between bile acid metabolism and microbiota in irritable bowel syndrome
Dior, M., Delagreverie, H. M., Duboc, H., Jouet, P., Coffin, B., Brot, L., Humbert, L., Trugnan, G., Seksik, P., Sokol, H., et al. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12829 · Cited by 128
Self-citation
Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
Altomare, A., Rosa, C. D., Imperia, E., Emerenziani, S., Cicala, M., & Guarino, M. P. L. (2021) · Nutrients · doi:10.3390/nu13051506 · Cited by 140
Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota
Joyce, S. A., & Gahan, C. G. M. (2017) · Digestive Diseases · doi:10.1159/000450907 · Cited by 130
Long-term impact of tylosin on fecal microbiota and fecal bile acids of healthy dogs
Manchester, A. C., Webb, C. B., Blake, A. B., Sarwar, F., Lidbury, J. A., Steiner, J. M., & Suchodolski, J. S. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15635 · Cited by 131
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115
The Interplay of the Gut Microbiome, Bile Acids, and Volatile Organic Compounds
Sagar, N. M., Cree, I. A., Covington, J. A., & Arasaradnam, R. P. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/398585 · Cited by 110
Review article: bile acid diarrhoea – pathogenesis, diagnosis and management
Mottacki, N., Simrén, M., & Bajor, A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13570 · Cited by 114
Longitudinal assessment of microbial dysbiosis, fecal unconjugated bile acid concentrations, and disease activity in dogs with steroid-responsive chronic inflammatory enteropathy
Guard, B. C., Honneffer, J. B., Jergens, A. E., Jonika, M. M., Toresson, L., Lawrence, Y. A., Webb, C. B., Hill, S. L., Lidbury, J. A., Steiner, J. M., et al. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15493 · Cited by 123
Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models
Miquel, S., Martín, R., Lashermes, A., Gillet, M., Meleine, M., Gelot, A., Eschalier, A., Ardid, D., Bermúdez-Humarán, L. G., Sokol, H., et al. (2016) · Scientific Reports · doi:10.1038/srep19399 · Cited by 105
Self-citation
Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy
Walters, J. R. F. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.32 · Cited by 104
Luminal Cysteine-Proteases Degrade Colonic Tight Junction Structure and Are Responsible for Abdominal Pain in Constipation-Predominant IBS
Annaházi, A., Ferrier, L., Bézirard, V., Lévêque, M., Eutamène, H., Ait-Belgnaoui, A., Coëffier, M., Ducrotté, P., Róka, R., Inczefi, O., et al. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.152 · Cited by 96
The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
Mazzawi, T., Lied, G. A., Sangnes, D. A., El-Salhy, M., Hov, J. R., Gilja, O. H., Hatlebakk, J. G., & Hausken, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194904 · Cited by 92
Comparison of intestinal expression of the apical sodium-dependent bile acid transporter between dogs with and without chronic inflammatory enteropathy
Giaretta, P. R., Rech, R. R., Guard, B. C., Blake, A. B., Blick, A. K., Steiner, J. M., Lidbury, J. A., Cook, A. K., Hanifeh, M., Spillmann, T., et al. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15332 · Cited by 92
Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery
Ilhan, Z. E., DiBaise, J. K., Dautel, S. E., Isern, N., Kim, Y., Hoyt, D. W., Schepmoes, A., Brewer, H. M., Weitz, K., Metz, T., et al. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-0122-5 · Cited by 93
Advances in understanding of bile acid diarrhea
Camilleri, M. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.851599 · Cited by 92
Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease
Pereira-Fantini, P. M., Lapthorne, S., Joyce, S. A., Dellios, N. L., Wilson, G., Fouhy, F., Thomas, S., Scurr, M., Hill, C., Gahan, C. G. M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.025 · Cited by 91
Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain
Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 92
Role of gut microbiota-derived signals in the regulation of gastrointestinal motility
Zheng, Z., Tang, J., Hu, Y., & Zhang, W. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.961703 · Cited by 94
High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria
Aziz, I., Mumtaz, S., Bholah, H., Chowdhury, F. U., Sanders, D. S., & Ford, A. C. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.03.002 · Cited by 87
Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242
Martoni, C. J., Labbé, A., Ganopolsky, J. G., Prakash, S., & Jones, M. L. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1005474 · Cited by 87
Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism
Enright, E. F., Griffin, B. T., Gahan, C. G. M., & Joyce, S. A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.009 · Cited by 91
Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications
Napolitano, M., Fasulo, E., Ungaro, F., Massimino, L., Sinagra, E., Danese, S., & Mandarino, F. V. (2023) · Microorganisms · doi:10.3390/microorganisms11102369 · Cited by 100
Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples
Vijayvargiya, P., Busciglio, I. A., Burton, D. D., Donato, L. J., Lueke, A. J., & Camilleri, M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.039 · Cited by 84
Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome
Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Artacho, A., Garrigues, V., Ortiz, V., Ponce, J., Latorre, A., & Moya, A. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12184 · Cited by 83
Effects of β-Lactam Antibiotics and Fluoroquinolones on Human Gut Microbiota in Relation to Clostridium difficile Associated Diarrhea
Knecht, H., Neulinger, S. C., Heinsen, F., Knecht, C., Schilhabel, A., Schmitz, R. A., Zimmermann, A., dos Santos, V. A. P. M., Ferrer, M., Rosenstiel, P. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089417 · Cited by 87
Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome
Wei, W., Wang, H., Zhang, Y., Zhang, Y., Niu, B.-Y., & Yao, S. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i45.7153 · Cited by 81
Microbiota: a novel regulator of pain
Defaye, M., Gervason, S., Altier, C., Berthon, J., Ardid, D., Filaire, E., & Carvalho, F. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02083-z · Cited by 81
The networks of human gut microbe–metabolite associations are different between health and irritable bowel syndrome
Shankar, V., Homer, D., Rigsbee, L., Khamis, H. J., Michail, S. K., Raymer, M. L., Reo, N. V., & Paliy, O. (2015) · The ISME Journal · doi:10.1038/ismej.2014.258 · Cited by 77
Structural and Functional Alterations in the Microbial Community and Immunological Consequences in a Mouse Model of Antibiotic-Induced Dysbiosis
Shi, Y., Kellingray, L., Zhai, Q., Gall, G. L., Narbad, A., Zhao, J., Zhang, H., & Chen, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01948 · Cited by 80
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Mei, L., Zhou, J., Su, Y., Mao, K., Wu, J., Zhu, C., He, L., & Cui, Y. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01693-w · Cited by 76
Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin
Heinsen, F., Knecht, H., Neulinger, S. C., Schmitz, R. A., Knecht, C., Kühbacher, T., Rosenstiel, P. C., Schreiber, S., Friedrichs, A. K., & Ott, S. J. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1062959 · Cited by 75
The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium
Sarathy, J., Detloff, S. J., Ao, M., Khan, N., French, S., Sirajuddin, H., Nair, T., & Rao, M. C. (2017) · Physiological Reports · doi:10.14814/phy2.13294 · Cited by 72
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study
Biase, A. R. D., Marasco, G., Ravaioli, F., Dajti, E., Colecchia, L., Righi, B., D’Amico, V., Festi, D., Iughetti, L., & Colecchia, A. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15183 · Cited by 73
Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome
Bao, C., Wang, C., Li, G., Yan, Y., Wang, D., Jin, X., Wu, L., Liu, H., Wang, X., Shi, Z., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i32.4696 · Cited by 70
Gut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome
Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 72
Current Practice in the Diagnosis of Bile Acid Diarrhea
Vijayvargiya, P., & Camilleri, M. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.069 · Cited by 70
New insights into irritable bowel syndrome: from pathophysiology to treatment
Hadjivasilis, A. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0428 · Cited by 76
Irritable bowel syndrome, inflammatory bowel disease and the microbiome
Major, G., & Spiller, R. E. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000032 · Cited by 67
The role of bile acids in functional GI disorders
Appleby, R., & Walters, J. R. F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12370 · Cited by 66
Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases
Yang, T., Khan, G. J., Wu, Z., Wang, X., Zhang, L., & Jiang, Z. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.007 · Cited by 65
Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea
Vijayvargiya, P., Camilleri, M., Chedid, V. G., Carlson, P., Busciglio, I. A., Burton, D. D., & Donato, L. J. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.050 · Cited by 62
Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
Min, Y. W., Rezaie, A. R., & Pimentel, M. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22129 · Cited by 69
Microbiota-Related Changes in Unconjugated Fecal Bile Acids Are Associated With Naturally Occurring, Insulin-Dependent Diabetes Mellitus in Dogs
Jergens, A. E., Guard, B. C., Redfern, A., Rossi, G., Mochel, J. P., Pilla, R., Chandra, L. C., Seo, Y., Steiner, J. M., Lidbury, J. A., et al. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00199 · Cited by 65
Emerging science of the human microbiome
Jones, M. L., Ganopolsky, J. G., Martoni, C., Labbé, A., & Prakash, S. (2014) · Gut Microbes · doi:10.4161/gmic.29810 · Cited by 57
Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome–Diarrhea Without Bile Acid Malabsorption
Peleman, C., Camilleri, M., Busciglio, I. A., Burton, D. D., Donato, L. J., & Zinsmeister, A. R. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.11.012 · Cited by 59
Targeting strategies for chemotherapy-induced peripheral neuropathy: does gut microbiota play a role?
Zhong, S., Zhou, Z., Liang, Y., Cheng, X., Li, Y., Teng, W., Zhao, M., Liu, C., Guan, M., & Zhao, C. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1608905 · Cited by 56
Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients
Liu, T., Gu, X., Li, L., Li, M., Li, B., Cui, X., & Zuo, X. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01841-4 · Cited by 58
The Pathophysiology of Bile Acid Diarrhoea: Differences in the Colonic Microbiome, Metabolome and Bile Acids
Sagar, N., Duboc, H., Kay, G. L., Alam, M. T., Wicaksono, A. N., Covington, J. A., Quince, C., Kokkorou, M., Svolos, V., Palmieri, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77374-7 · Cited by 56
Self-citation
Functional Gastrointestinal Disorders and the Microbiome—What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?
Mars, R. A. T., Frith, M., & Kashyap, P. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.058 · Cited by 53
The microbiome and childhood diseases: Focus on brain‐gut axis
O’Mahony, S. M., Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21118 · Cited by 53
The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge
Mari, A., Baker, F. A., Mahamid, M., Sbeit, W., & Khoury, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030685 · Cited by 57

Authors: Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., Sokol, H., Coffin, B., & Sabaté, J. M.
Affiliations: Inserm (FR)
Corresponding author: Duboc, H.
ORCID: Duboc, H.
Rainteau, D.
Bouhassira, D.
Seksik, P.
Sokol, H.
Coffin, B.
Sabaté, J. M.
Venue: Neurogastroenterology & Motility
Publisher: Wiley
Published: 2012-02-22
Volume: 24
Issue: 6
Pages: 513
ISSN: 1350-1925 (ISSN-L)
1365-2982
DOI: 10.1111/j.1365-2982.2012.01893.x
OpenAlex: W1482883615
Cited by: 256
References: 42
Citations by year: 2026: 15 · 2025: 9 · 2024: 12 · 2023: 20 · 2022: 22 · 2021: 26 · 2020: 23 · 2019: 23 · 2018: 13 · 2017: 17 · 2016: 19 · 2015: 18 · 2014: 21 · 2013: 15 · 2012: 3
FWCI: 17.76
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Neurogastroenterology & Motility (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords: diarrhea-predominant irritable bowel syndrome, primary bile acids, fecal bile acids, gut dysbiosis, stool consistency, stool frequency, Escherichia coli, Faecalibacterium prausnitzii, Leptospirillum, Bifidobacterium, lactobacilli
MeSH terms: Adult, Bile Acids and Salts, Colon, Diarrhea, DNA, Bacterial, Feces, Female, Humans, Intestinal Mucosa, Male, Middle Aged, Irritable Bowel Syndrome, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks